MAMarcela Lopes de Almeida

Marcela Lopes de Almeida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcela Lopes de Almeida has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Broadening the Movement Disorder Spectrum in MECP2 ‐Related Disorders: From Ataxia to Opsoclonus‐Myoclonus

    by Bruno Antunes Contrucci, Maria Victoria Suguitani Santello, Marcela Lopes de Almeida, Rafaela Pichini de Oliveira, Vitor Tumas, Ana Paula Andrade Hamad, Guillermo Andrey Ariza Traslaviña, Carla Andrea Cardoso Tanuri Caldas

    Background: MECP2 ‐related disorders encompass a broad spectrum of movement disorders, but opsoclonus has not been characterized within this spectrum. Case Presentation: We describe a girl with a de novo pathogenic MECP2 variant who developed an acute/subacute cerebellar presentation following a prolonged febrile illness, evolving from prominent axial ataxia to multifocal myoclonus and opsoclonus. Hyperkinetic manifestations improved with corticosteroid therapy, whereas developmental impairment persisted. Discussion/Conclusion: This unusual longitudinal phenotype broadens the recognized movement disorder spectrum in MECP2 ‐related disorders and highlights how an evolving neurogenetic condition may clinically resemble an acquired neuroinflammatory syndrome.

  • Open Access

    GLRB ‐Related Hyperekplexia Presenting as Neonatal Seizure‐Like Events

    by Bruno Antunes Contrucci, Hugo Matos Bandeira, Sofia Tonin Angonese, Marcela Lopes de Almeida, Rafaela Pichini de Oliveira, Vitor Tumas, Ana Paula Andrade Hamad, Guillermo Andrey Ariza Traslaviña, Carla Andrea Cardoso Tanuri Caldas

  • Open Access

    Epileptic–Dyskinetic Encephalopathy Associated with a PPP3CA Variant: Expansion of the Phenotypic Spectrum

    by Bruno Antunes Contrucci, Ursula Thomé, Larissa Aparecida Batista, Ana Laura Volpi Martins Lorenzoni, Carla Andrea Cardoso Tanuri Caldas, Americo Ceiki Sakamoto, Israel Gomy, Lisandra Mesquita Batista, Marcela Lopes de Almeida, Ana Paula Andrade Hamad, et al.

  • Open Access

    The role of thoracic ultrasound in fluid management in critical care: a narrative review

    by Rogerio da Hora Passos, Leonardo Van De Wiel Barros Urbano Andari, Marcela de Almeida Lopes, Vinicius Barbosa Galindo, Uri Adrian Prync Flato, Roberto Camargo Narciso, Carolina de Moraes Pellegrino, Thais Dias Midega, Renan Sandoval de Almeida, Fernanda Oliveira Coelho, et al.

    Fluid management remains central to critical care, requiring a careful balance between early resuscitation and the prevention or reversal of pulmonary and systemic congestion. Thoracic ultrasound (TUS) offers real-time, organ-specific assessment of extravascular lung water (EVLW) and pleural effusion, helping clinicians recognize both fluid responsiveness and fluid intolerance—an increasingly relevant distinction in acute respiratory distress syndrome (ARDS), acute heart failure, kidney replacement therapy, and shock. This review synthesizes current evidence on TUS-guided fluid administration and removal and introduces the Fluid Responsiveness & Tolerance, Lung Congestion, Ultrafiltration Optimization, Individualized Therapy, Differentiating Shock (FLUID) framework as a practical bedside reasoning tool emphasizing repeated reassessment rather than prescriptive thresholds. Narrative review of PubMed, Scopus, and Embase (January 2015 to January 2025), supplemented by landmark earlier articles when clinically relevant. Eligible studies included adult human research, systematic reviews, randomized trials, and consensus statements. Editorials, pediatric, and veterinary studies were excluded. Selection and full-text appraisal were performed independently by two reviewers. TUS provides bedside visualization of pulmonary congestion through B-lines, lung ultrasound scoring, and effusion monitoring, improving detection of EVLW compared with physical examination or central venous pressure. Integrated with focused cardiac and venous Doppler evaluation, TUS supports decisions regarding resuscitation, diuretic escalation, ultrafiltration, or fluid removal in ARDS, heart failure, and shock. Evidence suggests TUS-guided strategies may reduce cumulative fluid balance and rehospitalization in heart failure and may facilitate ventilator liberation, though definitive outcome effects remain under investigation. The FLUID framework structures iterative bedside reasoning without functioning as a prescriptive protocol. TUS is a practical and repeatable tool that enhances individualized fluid management by identifying evolving pulmonary congestion and estimating fluid tolerance. The FLUID framework supports structured clinical integration of ultrasound findings but requires further prospective validation. Future trials and artificial intelligence (AI)-assisted quantification tools may help standardize practice and clarify outcome benefits.


  • Open Access

    Phenotypic and Genotypic Variability in Niemann-Pick Type C: A Brazilian Case Series

    by Marcela L. Almeida, Carolina A. R. Funayama, Wilson Marques, Carla A. C. T. Caldas, Charles M. Lourenço, Ana P. A. Hamad, Guillermo A. A. Traslaviña

    Niemann-Pick disease type C (NPC) disease is a lysosomal storage disorder caused by alterations in the trafficking of unesterified cholesterol due to mutations in the NPC1 and NPC2 genes. Its manifestations can be visceral, neurological, and psychiatric. This study conducts a retrospective review to assess the clinical, laboratory, molecular, and imaging features of a cohort of Brazilian patients with NPC. Eleven cases were included, 6 females and 5 males, aged between 3 and 32 years. Three cases corresponded to the early infantile form, three to the late infantile form, four to the juvenile, and one to the adult form. The most frequent symptoms were splenomegaly (10/11), hepatomegaly (8/11), vertical supranuclear gaze palsy (11/11), ataxia (10/11), dysarthria (10/11), dysphagia (10/11), spasticity (7/11), epilepsy (7/11), dystonia (7/11), cognitive impairment (8/11), and school delay (8/11). All patients exhibited non-specific abnormalities in brain imaging studies. Biomarker-specific tests were positive in 9 out of 11 cases. The Filipin test was "classic" in 6 cases and "variant" in 5. Mutations in NPC1 were identified in all patients, with the most prevalent variant being p.Ala1035Val (8/11). This case series highlights the p.Ala1035Val mutation in NPC1 correlates with the "classic" profile of Filipin staining.

  • Open Access

    Hipoventilação relacionada ao sono de origem central secundária à deficiência de biotinidase: relato de caso

    by Andressa Fernandes Silva, Carolina Vicentim de Moraes, Guilherme Andrade Pelissari, Zumira Aparecida Carneiro, Marcela Almeida Lopes, Taciane Borsatto, Ida Vanessa Doederlein Schwartz, Charles Marques Lourenço

    A hipoventilação relacionada ao sono de origem central resulta em hipercapnia relacionada ao sono na vigência de condições normais do sistema respiratório e excluindo-se outros fatores. Os pacientes portadores dessa patologia podem se apresentar assintomáticos ou com queixas de cefaleia matinal, déficit cognitivo e fadiga, além de eventos como a observação de respiração superficial. No presente relato, descreve-se o caso de uma paciente de 3 anos, com exame físico geral e neurológico normais, desenvolvimento neuropsicomotor adequado, apresentando irregularidades respiratórias e bradicardia durante o sono. Encaminhada para investigação de distúrbios respiratórios do sono, sendo diagnosticada com hipoventilação relacionada ao sono. Através do estudo genético, evidenciou-se a deficiência de biotinidade como a possível ãcausa da sintomatologia, comprovada por dosagens enzimáticas e teste genético molecular. O tratamento medicamentoso foi iniciado precocemente, determinando resolução dos sintomas descritos. A importância do presente relato se encontra na apresentação da deficiência da biotinidase com quadro cardiorrespiratório isolado em criança neurologicamente normal, ademais trata-se de um caso em que a etiologia de Breath-Holding Speels foi a deficiência dessa enzima. Correspondência sugerida pela resolução da hipoventilação central após a introdução da biotina. Além disso, nesse caso, os sintomas ALTE, que aterrorizam o observador e até o profissional, foram solucionados com tratamento simples, a ingesta oral de biotina. Esse relato de caso corrobora com a expansão das possibilidades de manifestações fenotípicas das formas tardias de deficiência de biotinidase, como o fenótipo da SHC.